dihexa chemical structure | CAS 1401708-83-5 Dihexa (PNB-0408) | c-Met/HGFR Activator

BPC-157 is supplied for Research Use Only (RUO)

In the literature, Tirzepatide has been studied in relation to: body-weight regulation and appetite signalling glucose metabolism and glycaemic markers insulin signalling and nutrient handling energy balance and systemic metabolic regulation comparative incretin research across GLP-1, dual agonist and triple agonist models For researchers building a metabolic peptide panel, Tirzepatide often serves as the central comparator molecule between Semaglutide and Retatrutide

In published preclinical research, BPC-157 has been administered at doses ranging from 6 to 50 micrograms per kilogram body weight in animal models, with most tissue-repair and gastric-protection protocols using 10 to 20 mcg/kg once or twice daily (PMID 21030672, PMID 32558293, PMID 38980576)

The authors reported improved Morris water maze performance (reduced escape latency over the training days), increased synaptophysin (a synaptic-density marker), and lower IL-1 and TNF-, with effects attributed to PI3K/AKT signaling